Johnson and Johnson is in the last stages of getting the new EVARREST Patch approved by the FDA. The patch is meant to alleviate pain of patients who suffering from atypical and prolonged hemorrhaging. Morayma Reyes is the Assistant Professor in the Department of Pathology at the University of Washington.